EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of an In Vitro DSS-Induced Epithelial Injury Model to Investigate Dose-Dependent Effects of IL-6 and Butyrate on Barrier Function

Srijal Kunwar iD, Saleh A Naser iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Srijal Kunwar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816, USA. Hauptthemen laut MEDLINE: Interleukin-6, Dextran Sulfate, Butyrates, Intestinal Mucosa. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Florida Legislative Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dextran sodium sulfate (DSS) is widely used in vivo to induce epithelial injury; however, the epithelial-specific responses to DSS and mechanisms associated with barrier restoration remain incompletely understood. Here, we establish an in vitro DSS-induced epithelial damage model using differentiated Caco-2 cell monolayers. Exposure to 2.5%(w/v) DSS for 24 h resulted in significant upregulation of the pore-forming protein Claudin-2(CLDN2) (2.677-fold) and elevated oxidative marker protein levels of NADPH oxidase 1 (NOX1), accompanied by increased reactive oxygen species (ROS) production confirmed via dihydroethidium (DHE) staining. Increased epithelial permeability was observed by transepithelial electrical resistance (TEER) analysis, without significant cytotoxicity. Surprisingly, ELISA analysis revealed significant downregulation of Interleukin-6 (IL-6) (0.364 ± 0.034 pg/mL) following DSS exposure. Treatment with 1 ng/mL recombinant IL-6 (rIL-6) improved epithelial barrier function during continued DSS exposure, whereas a higher dose of 5 ng/mL did not produce the same restorative response. Furthermore, treatment of DSS-damaged Caco-2 monolayer with 10 mM butyrate significantly improved epithelial barrier function. Collectively, this study establishes a reproducible DSS-induced Caco-2 epithelial injury model and demonstrates concentration-dependent effects of rIL-6 and barrier-restorative effects of butyrate, providing an epithelial-specific platform for investigating intestinal barrier dysfunction relevant to IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6Dextran SulfateButyratesIntestinal MucosaEpithelial CellsHumansCaco-2 CellsIntestinal Barrier FunctionReactive Oxygen SpeciesClaudin-2PermeabilityClaudins

Stichwörter der Autor:innen

Caco-2IL-6butyratecytokinesdextran sodium sulfate (DSS)epithelial barrierinflammatory bowel disease (IBD)

Substanzen

Interleukin-6Dextran SulfateReactive Oxygen SpeciesButyratesClaudin-2CLDN2 protein, humanClaudins

Autor:innen und Institutionen

  • Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816, USA.

ORCID-Profile: Srijal Kunwar, Saleh A Naser

Förderung

  • Florida Legislative Grant

Zitieren

APA

Kunwar, S., & Naser, S. A. (2026). Establishment of an In Vitro DSS-Induced Epithelial Injury Model to Investigate Dose-Dependent Effects of IL-6 and Butyrate on Barrier Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188028

Vancouver

Kunwar S, Naser SA. Establishment of an In Vitro DSS-Induced Epithelial Injury Model to Investigate Dose-Dependent Effects of IL-6 and Butyrate on Barrier Function. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188028

BibTeX
@article{Kunwar2026,
  author = {Kunwar, Srijal and Naser, Saleh A},
  title = {Establishment of an In Vitro DSS-Induced Epithelial Injury Model to Investigate Dose-Dependent Effects of IL-6 and Butyrate on Barrier Function},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188028}
}
Kostenlos starten →